Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium (laserphyrin): a preclinical study.

Horimatsu T, Muto M, Yoda Y, Yano T, Ezoe Y, Miyamoto S, Chiba T.

PLoS One. 2012;7(6):e38308. doi: 10.1371/journal.pone.0038308. Epub 2012 Jun 13.

2.

Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer.

Yano T, Muto M, Yoshimura K, Niimi M, Ezoe Y, Yoda Y, Yamamoto Y, Nishisaki H, Higashino K, Iishi H.

Radiat Oncol. 2012 Jul 23;7:113. doi: 10.1186/1748-717X-7-113.

3.

Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration.

Yoshida T, Tokashiki R, Ito H, Shimizu A, Nakamura K, Hiramatsu H, Tsukahara K, Shimizu S, Takata D, Okamoto I, Suzuki M.

Auris Nasus Larynx. 2008 Dec;35(4):545-51. doi: 10.1016/j.anl.2007.10.008. Epub 2008 Feb 1.

PMID:
18242905
4.
5.

Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.

Akimoto J, Haraoka J, Aizawa K.

Photodiagnosis Photodyn Ther. 2012 Jun;9(2):91-9. doi: 10.1016/j.pdpdt.2012.01.001. Epub 2012 Feb 28.

PMID:
22594978
6.

Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630 nm laser light in canine esophagus.

Panjehpour M, DeNovo RC, Petersen MG, Overholt BF, Bower R, Rubinchik V, Kelly B.

Lasers Surg Med. 2002;30(1):26-30.

PMID:
11857600
7.

Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.

van Den Boogert J, van Staveren HJ, de Bruin RWF, de Rooij FWM, Edixhoven-Bosdijk A, Siersema PD, van Hillegersberg R.

J Photochem Photobiol B. 2000 Jun;56(1):53-60.

PMID:
11073316
8.

Comparison of reduced and standard light application in photodynamic therapy of the eye in two rabbit models.

Framme C, Flucke B, Birngruber R.

Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):773-81. Epub 2006 Jan 27.

PMID:
16440207
9.

Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.

Gill KR, Wolfsen HC, Preyer NW, Scott MV, Gross SA, Wallace MB, Jones LR.

Clin Cancer Res. 2009 Mar 1;15(5):1830-6. doi: 10.1158/1078-0432.CCR-08-2317. Epub 2009 Feb 24.

10.

Monte carlo model of stricture formation in photodynamic therapy of normal pig esophagus.

Jones LR, Preyer NW, Wolfsen HC, Reynolds DM, Davis MA, Wallace MB.

Photochem Photobiol. 2009 Jan-Feb;85(1):341-6. doi: 10.1111/j.1751-1097.2008.00445.x.

PMID:
19161398
11.

Photodynamic therapy using talaporfin sodium for synovial membrane from rheumatoid arthritis patients and collagen-induced arthritis rats.

Torikai E, Kageyama Y, Kohno E, Hirano T, Koide Y, Terakawa S, Nagano A.

Clin Rheumatol. 2008 Jun;27(6):751-61. Epub 2007 Dec 8.

PMID:
18066613
12.

Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.

Ortner M-, Zumbusch K, Liebetruth J, Ebert B, Fleige B, Dietel M, Lochs H.

Endoscopy. 2002 Aug;34(8):611-6.

PMID:
12173080
13.

Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model.

Radu A, Conde R, Fontolliet C, Wagnieres G, Van den Bergh H, Monnier P.

Gastrointest Endosc. 2003 Jun;57(7):897-905.

PMID:
12776039
14.

Experimental research photodynamic effects in perifocal, oedematous brain tissue.

Goetz C, Hasan A, Stummer W, Heimann A, Kempski O.

Acta Neurochir (Wien). 2002 Feb;144(2):173-9; discussion 179.

PMID:
11862518
15.

A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors.

Lustig RA, Vogl TJ, Fromm D, Cuenca R, Alex Hsi R, D'Cruz AK, Krajina Z, Turić M, Singhal A, Chen JC.

Cancer. 2003 Oct 15;98(8):1767-71.

16.

PEG-m-THPC-mediated photodynamic effects on normal rat tissues.

Hornung R, Fehr MK, Walt H, Wyss P, Berns MW, Tadir Y.

Photochem Photobiol. 2000 Nov;72(5):696-700.

PMID:
11107857
17.

Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.

Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW.

Ophthalmology. 1999 Oct;106(10):1915-23.

PMID:
10519585
18.

A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.

Orenstein A, Kostenich G, Roitman L, Shechtman Y, Kopolovic Y, Ehrenberg B, Malik Z.

Br J Cancer. 1996 Apr;73(8):937-44.

19.

Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.

Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, Szeimies RM, Zwingers T, Hönigsmann H, Tanew A.

Br J Dermatol. 2005 Feb;152(2):279-83.

PMID:
15727639
20.
Items per page

Supplemental Content

Write to the Help Desk